Medicare Advantage enrollment hit 33 million last year, up 8% from 2023. Everyone — hospitals, analysts, even CMS — expected smooth sailing as seniors flocked to these private plans promising extras like dental and gym memberships. But Jefferson Health just shattered that complacency, slapping Aetna with a lawsuit over sneaky payment reductions that could cost providers millions.
This Philly powerhouse isn’t alone in its gripe. Teaming with Lehigh Valley Physician Hospital Organization, they’re calling out Aetna’s ‘level of severity inpatient payment policy’ — a January 1 rollout that downgrades approved inpatient stays to cheaper ‘observation’ rates if the insurer deems patients not sick enough.
Picture this: a 72-year-old rolls into the ER with altered mental status, a stroke history, hypoxia. Doctors intubate, ICU time, acute renal failure hits, pneumonia sets in. Yet after two midnights, Aetna labels it ‘low severity.’
“After the patient’s second midnight in the hospital, Aetna determined the patient was ‘low severity,’ even though the patient was intubated in an ICU, had acute renal failure, and was administered broad spectrum IV antibiotics for multifocal pneumonia. The admitting physician determined the patient’s inpatient stay was medically necessary, but Aetna decided the patient was not ‘severe’ enough to qualify for payment at an inpatient rate.”
That’s straight from the complaint. Brutal.
What Sparked This Medicare Advantage Uprising?
Hospitals saw MA as a goldmine — higher reimbursements than traditional Medicare, right? Wrong, increasingly. Payers like Aetna tightened the screws post-pandemic, ramping up denials and audits. Jefferson claims this policy straight-up breaches their contract, ignores CMS’s two-midnight rule, and shifts risk unfairly onto providers.
Downcoding legit inpatient care? It slashes revenue — observation pays 30-50% less — and piles on appeal paperwork. Small practices, already drowning in admin, can’t keep up. Jefferson wants an injunction, damages, fees. Aetna? Stonewalls.
“Aetna’s policies, including the Level of Severity Inpatient Payment Policy, comply with all applicable federal law and regulations and with the terms of our provider contracts. Aetna disagrees with the allegations in the lawsuit and will respond in the appropriate forum.”
Polished PR spin. But here’s my take: this reeks of cost-shifting in a $400 billion market where MA plans pocketed $15 billion in overpayments last year, per HHS audits.
Short stays — one to four midnights — get hit hardest, even with physician sign-off. CMS says expect two midnights? Pay inpatient. MA plans? Nah, we’ll decide severity. It’s a power grab, unilateral, unnegotiated.
Why Does Aetna’s ‘Severity’ Policy Feel Like a Bait-and-Switch?
Market dynamics shifted hard. MA star ratings dipped for some plans amid scrutiny; enrollment growth slowed to 3% projections for 2025. Payers face rebate cliffs if they don’t control costs. Enter severity tiers — a new invention to claw back bucks.
Jefferson nails it: this violates federal guidelines MA must mirror. Remember the 2019 MA crackdown? CMS clawed back billions for upcoding. Now providers flip the script, alleging downcoding. Poetic justice, or market correction?
My unique angle — this echoes the 1990s HMO backlash. Back then, ‘gag clauses’ and denial wars tanked enrollment 20%. If Jefferson prevails, expect a lawsuit tsunami. MA margins? Squeezed 15-20% as hospitals demand contract overhauls.
Data backs the frustration. American Hospital Association reports MA denials doubled since 2020; 20% overturn rate on appeals. Philly’s Jefferson — 20 hospitals, $8B revenue — isn’t some mom-and-pop. Their win could cascade, forcing payers to rethink short-stay games.
Aetna’s not flinching, but they’re bleeding providers. UnitedHealth, Humana face similar heat. National fight brewing.
Will This Lawsuit Upend Medicare Advantage Payments?
Short answer: yes, if it sticks. Courts have sided with hospitals before — think Norcal Mutual ruling on two-midnight compliance. A Jefferson injunction halts Aetna’s policy nationwide? Chaos for short-stay billing. Payers pivot to pre-authorizations, worsening delays.
Bold prediction: MA growth stalls at 30 million by 2027, down from 40M forecasts. Seniors hear ‘denial horror stories,’ bolt back to traditional Medicare. Investors, note: Aetna parent CVS Health stock dipped 2% on news; broader sector wobbles.
Providers aren’t blameless — overutilization’s real — but this feels like overreach. Aetna’s defending in ‘appropriate forum’? Code for ‘delay and settle.’ Don’t buy the hype.
Broader implications? Small practices shutter — 1,200 closed since 2020, partly admin crush. Equity hit: rural spots suffer most.
Why Hospitals Are Drawing a Line in the Sand Now
Frustration peaked. MA promised upside; delivers headaches. Jefferson’s suit — filed Monday — times perfectly with CMS’s 2026 rate cuts (0.2% bump, barely inflation). Payers squeeze harder; hospitals punch back.
One punchy fact: MA pays 104% of Medicare fee-for-service on average, but short-stay variances erase that. Skewed incentives.
🧬 Related Insights
- Read more: TrustX Health: NHS’s Shiny New AI Badge, Same Old Risks
- Read more: Anthropic’s Claude Code Leak Becomes Hacker Bait — Malware Lurks in GitHub Repos
Frequently Asked Questions
What is Aetna’s level of severity inpatient payment policy?
It downgrades some approved inpatient Medicare Advantage stays to observation rates for ‘low severity’ cases, even 1-4 midnights long, if Aetna says so.
Will Jefferson Health win its lawsuit against Aetna?
Strong shot — CMS two-midnight rule favors docs over payers; similar cases won before. But appeals drag on years.
How does this affect Medicare Advantage for patients?
Potentially longer ER waits, fewer providers if hospitals exit MA networks over payment fights.
